Given the role of NMNAT2 in axon survival (1, 2), the finding that zDHHC17 could regulate NMNAT2 palmitoylation suggests a potential impairment of NMNAT2 palmitoylation and subcellular targeting in Huntington disease models that warrants further investigation. Here, NMNAT2 is linked to juvenile Huntington disease.